Evidence map›Paper›PMID 41615146›Full record

ArticleMicrobiology spectrum2026

Sara Maestrini, Aurora Diotallevi, Sarah Hijazi, Sara Habouria, Emanuela Frangipani, Luca Galluzzi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara MaestriniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy.ORCID 0009-0007-2849-6772
Aurora DiotalleviDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy.ORCID 0000-0001-5456-1821
Sarah HijaziDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy.ORCID 0000-0002-0064-4610
Sara HabouriaLaboratory of Transmission, Control and Immunobiology of Infection, Institut Pasteur de Tunis, Tunis, Tunisia.
Emanuela FrangipaniDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy.ORCID 0000-0001-5619-7912
Luca GalluzziDepartment of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino (PU), Italy.ORCID 0000-0002-1747-526X

Funding

European Union - NextGenerationEU, Mission 4, Component 2, under the Italian Ministry of University and Research, National Innovation Ecosystem Grant ECS00000041 - VITALITY - CUP H33C22000430006 ECS00000041 - VITALITY
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiprotozoal AgentsGalliumLeishmania infantumLeishmania majorProtoporphyrinsAnimalsHumansMacrophagesPhosphorylcholineAntiprotozoal AgentsGalliumPhosphorylcholineprotoporphyrin IXProtoporphyrinsanti-parasitic drugsGaPPIXheme-mimeticiron starvationLeishmania

Identifiers

PMID41615146
PMCPMC12955387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.